UBP Greater China (Shanghai) Co., Ltd
5 clinical trials · Sponsor
◉ Watch UBP Greater China (Shanghai) Co., Ltd
| Record | Firm | Date |
|---|---|---|
| A Proof of Concept Study to Evaluate the Effect of UB-421 in Combination With Chidamide on HIV Viral Reservoir (NCT04985890) | UBP Greater China (Shanghai) Co., Ltd | 2024-03-01 |
| The HIV Functional Cure Potential of UB-421 in ART Stabilized HIV-1 Patients (NCT04404049) | UBP Greater China (Shanghai) Co., Ltd | 2023-12-01 |
| Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of UB-221 in Healthy Volunteers (NCT04404023) | UBP Greater China (Shanghai) Co., Ltd | 2023-12-01 |
| Evaluating Safety and Efficacy of Repeat Doses of UB-621in Adult Patients With Recurrent Genital Herpes (NCT04979975) | UBP Greater China (Shanghai) Co., Ltd | 2023-12-01 |
| UB-621, a New Type of Anti-herpes Simplex Virus (HSV) Monoclonal Antibody for the Use in the Treatment of Adult Recurrent HSV-2 Infections of the Genitals (NCT04714060) | UBP Greater China (Shanghai) Co., Ltd | 2023-10-01 |
Track UBP Greater China (Shanghai) Co., Ltd automatically
Every clearance here is in the API, with alerts when new ones post.